Table 3 Virologic Outcomes of EI-AED Compared to Non-AED Subjects
EI-AED (N = 19) | Non-AED (N = 190) | OR (95% CI) or Difference ± SE | Adjusted for VL at HAART Initiation OR (95% CI) or Difference ± SE | |
|---|---|---|---|---|
First HAART/AED Overlap | ||||
Virologic failure | 10/16 (62.5%) | 62/146 (42.5%) | 2.26 (0.78 - 6.54) P = 0.134 | 4.30 (1.02 - 18.07) P = 0.046 |
Average VL during period (log10) | 3.3 ± 1.3 (n = 19) | 2.9 ± 1.2 (n = 184) | 0.4 ± 0.3; P = 0.198 | 0.3 ± 0.3; P = 0.195 |
VL <400 at 6 months | 4/12 (33.3%) | 89/160 (55.6%) | 0.40 (0.12 - 1.38) P = 0.146 | 0.30 (0.06 - 1.48) P = 0.139 |
VL <400 at 12 months | 4/11 (36.4%) | 80/125 (64.0%) | 0.32 (0.09 - 1.16) P = 0.083 | 0.17 (0.03 - 0.89) P = 0.036 |